Provet Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.50 M
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.53 Cr
- Satisfied Charges ₹ 22.03 Cr
- Revenue Growth -30.39%
- Profit Growth -246.76%
- Ebitda -98.75%
- Net Worth -69.69%
- Total Assets -13.11%
About Provet Pharma
Provet Pharma Private Limited (PPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 October 2009 and has a history of 15 years and three months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹25.53 Cr. The company has closed loans amounting to ₹22.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Muthu Vengan and Suthanthirakumar Senthil serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231TN2009PTC073198
- Company No.
073198
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Provet Pharma Private Limited offer?
Provet Pharma Private Limited offers a wide range of products and services, including Autoclaves, Sterilizers & Incubators, Cold Chain Equipment, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Animal Medicines & Health Care, Veterinary Medicines, Anti Infective Drugs & Medicines, Antibacterial Drugs, Kids Fiction & Entertainment Books, School Book.
Who are the key members and board of directors at Provet Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muthu Vengan  | Managing Director | 14-Oct-2009 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suthanthirakumar Senthil | Director | 14-Oct-2009 | Current |
Financial Performance of Provet Pharma.
Provet Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 30.39% decrease. The company also saw a substantial fall in profitability, with a 246.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 69.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Provet Pharma?
In 2023, Provet Pharma had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Avantiva Animal Health Private LimitedMuthu Vengan and Suthanthirakumar Senthil are mutual person
Charges (Loans)
₹255.29 M
₹220.32 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 23.03 Cr
- Others : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Mar 2022 | Others | ₹2.50 Cr | Open |
| 25 Dec 2021 | Hdfc Bank Limited | ₹23.03 Cr | Open |
| 07 Mar 2017 | Others | ₹16.03 Cr | Satisfied |
| 28 Apr 2010 | Indian Bank | ₹6.00 Cr | Satisfied |
How Many Employees Work at Provet Pharma?
Provet Pharma has a workforce of 116 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Provet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Provet Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
